197721-29-2

Basic information

• Product Name: (S)-3-<1-oxo-2-(but-3-enyl-1-oxy)>-4-benzyl-2-oxazolidinone
• Synonyms: (S)-3-<1-oxo-2-(but-3-enyl-1-oxy)>-4-benzyl-2-oxazolidinone
• CAS NO: 197721-29-2
• Molecular Weight: 289.331
• Mol File: 197721-29-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (S)-3-<1-oxo-2-(but-3-enyl-1-oxy)>-4-benzyl-2-oxazolidinone(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-<1-oxo-2-(but-3-enyl-1-oxy)>-4-benzyl-2-oxazolidinone(197721-29-2)
• EPA Substance Registry System: (S)-3-<1-oxo-2-(but-3-enyl-1-oxy)>-4-benzyl-2-oxazolidinone(197721-29-2)

Safety Data

• Hazardous Substances Data: 197721-29-2(Hazardous Substances Data)

Upstream product

• 90719-32-7 (S)-4-Benzyl-2-oxazolidinone 
• 1070998-06-9 But-3-enyloxy-acetyl chloride 
• 95123-53-8 2-(but-3-en-1-yloxy)acetic acid 
• 79-37-8 oxalyl dichloride 

Downstream Products

• 197721-35-0 (S)-4-Benzyl-3-[(2S,3R)-2-but-3-enyloxy-6-(tert-butyl-diphenyl-silanyloxy)-3-hydroxy-hexanoyl]-oxazolidin-2-one 
• 197721-37-2 Acetic acid (R)-1-((R)-2-acetoxy-1-but-3-enyloxy-ethyl)-4-(tert-butyl-diphenyl-silanyloxy)-butyl ester 
• 239075-73-1 (4S)-3-<(2S,3R)-1-oxo-2-(but-3-enyl-1-oxy)-3-hydroxy-4-hexenyl>-4-benzyl-2-oxazolidinone 
• 197721-32-7 (4S)-3-<(2S,3R)-1-oxo-2-(but-3-enyl-1-oxy)-3-hydroxy-4-pentenyl>-4-benzyl-2-oxazolidinone 

Relevant articles and documents

SUBSTITUTED 4-ALKOXYOXAZOL DERIVATIVES AS PPAR AGONISTS

The present invention relates to compounds of formula (I) wherein R1 to R8 and n are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.

An asymmetric aldol - Ring-closing metathesis strategy for the enantioselective construction of oxygen heterocycles: An efficient approach to the enantioselective synthesis of (+)-laurencin

A strategy is described for the enantioselective construction of medium- ring cyclic ethers by merging the asymmetric aldol addition of glycolates with a ring-closing metathesis reaction. Cyclic ethers of seven-, eight-, and nine-membered rings are readil